86 related articles for article (PubMed ID: 2667728)
1. Lipoprotein (a): an emerging risk factor for atherosclerosis.
Hegele RA
Can J Cardiol; 1989; 5(5):263-5. PubMed ID: 2667728
[TBL] [Abstract][Full Text] [Related]
2. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
3. [Lipoprotein (a)--a further risk factor in arteriosclerosis?].
Ritter MM; Richter WO
Fortschr Med; 1990 Oct; 108(29):547-9, 554. PubMed ID: 2147016
[TBL] [Abstract][Full Text] [Related]
4. Plasma triglyceride-rich lipoprotein and high density lipoproteins disorders associated with atherosclerosis.
Genest J; Cohn J
J Investig Med; 1998 Oct; 46(8):351-8. PubMed ID: 9805418
[TBL] [Abstract][Full Text] [Related]
5. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis.
Scanu AM
Arch Pathol Lab Med; 1988 Oct; 112(10):1045-7. PubMed ID: 2972266
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein analysis. Early methods in the diagnosis of atherosclerosis.
Rosenfeld L
Arch Pathol Lab Med; 1989 Oct; 113(10):1101-10. PubMed ID: 2679486
[TBL] [Abstract][Full Text] [Related]
8. [Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms].
Lenzi S; Scanu A; De Caterina R
G Ital Cardiol; 1996 Oct; 26(10):1203-25. PubMed ID: 9005165
[TBL] [Abstract][Full Text] [Related]
9. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
11. Postprandial lipemia: emerging evidence for atherogenicity of remnant lipoproteins.
Cohn JS
Can J Cardiol; 1998 May; 14 Suppl B():18B-27B. PubMed ID: 9627538
[TBL] [Abstract][Full Text] [Related]
12. [Lipoprotein (a); a new 'independent' risk factor for atherosclerosis].
van Rijn HJ; Erkelens DW
Ned Tijdschr Geneeskd; 1992 Apr; 136(15):730-4. PubMed ID: 1532850
[No Abstract] [Full Text] [Related]
13. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.
Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A
Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250
[TBL] [Abstract][Full Text] [Related]
14. Atherosclerotic risk factors in cardiovascular disease.
LaRosa JC
J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a): a hereditary risk factor for atherosclerotic disease.
Donders SH; van Wersch JW
Neth J Med; 1992 Feb; 40(1-2):96-104. PubMed ID: 1533703
[No Abstract] [Full Text] [Related]
16. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins.
Tedeschi-Reiner E; Reiner Z; Sonicki Z
Croat Med J; 2004 Jun; 45(3):333-7. PubMed ID: 15185429
[TBL] [Abstract][Full Text] [Related]
18. [The significance of lipoprotein(a) in assessment of risk for atherosclerosis].
Kullich W; Machreich K
Wien Med Wochenschr; 1994; 144(17):407-11. PubMed ID: 7839688
[TBL] [Abstract][Full Text] [Related]
19. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M
Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590
[TBL] [Abstract][Full Text] [Related]
20. [Metabolism and possible mechanisms of atherogenesis induced by lipoprotein (a)].
Krempler F
Wien Klin Wochenschr Suppl; 1984; 151():1-12. PubMed ID: 6091345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
